AMOXICILLIN/CLAVULANAT EFFICIENCY FOR TREATMENT OF CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA

AMOXICILLIN/CLAVULANAT EFFICIENCY FOR TREATMENT OF CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA

Research goal — comparative evaluation of efficiency of amoxicillin/clavulanat versus unprotected penicillins and first generation cephalosporins for treatment of children with acute community acquired pneumonia. 62 children with acute pneumonia took part in the research. The main group was comprise...

Full description

Saved in:

Bibliographic Details
Main Authors:	O.I. Pikuza, A.M. Zakirova, E.A. Samorodnova, Kh.M. Vakhitov, T.B. Moroz
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2006-12-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/597
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review.
by: Rashmi Ranjan Das, et al.
Published: (2013-01-01)

Community-Acquired and Nosocomial Pneumonia: Clinical and Morphological Features
by: A. M. Golubev, et al.
Published: (2010-06-01)

FEATURES OF IMMUNE DISTURBANCES IN COMMUNITY-ACQUIRED PNEUMONIAS
by: G. A. Mavziutova, et al.
Published: (2014-07-01)

Immunological reactivity among young patients with community-acquired pneumonia and cytomegaloviral persistence
by: L. V. Moroz, et al.
Published: (2018-12-01)

Community-acquired pneumonia. Diagnosis, treatment approaches
by: A. A. Anderzhanova, et al.
Published: (2019-08-01)

Calculation of epidemic thresholds for incidence of community-acquired pneumonia
by: A. D. Botvinkin, et al.
Published: (2022-06-01)

The use of fluoroquinolones in the treatment of community-acquired pneumonia and their cardiotoxic effects
by: Gamayunov D.Yu., et al.
Published: (2024-12-01)

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
by: L. R. Mukhamadieva, et al.
Published: (2014-07-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
by: L. A. Demidchik, et al.
Published: (2016-05-01)

Assessment of current laboratory diagnosis of pneumococcal community-acquired pneumonia
by: Е. A. Koshkarina, et al.
Published: (2020-12-01)

Assessment of the prognosis of the outcome of severe community-acquired pneumonia caused by <i>Klebsiella pneumoniae</i>
by: V. I. Sakharov, et al.
Published: (2023-12-01)

Etiological Structure of Community-Acquired Pneumonia in the period of COVID-19 epidemic
by: V. I. Sergevnin, et al.
Published: (2024-03-01)

Toxicity analysis of amoxicillin, polyphosphate ester and its complex with amoxicillin on mice
by: Mariia Kozak, et al.
Published: (2025-05-01)

Diagnostic value of bronchoalveolar lavage in children with nonresponding community-acquired pneumonia
by: Chih-Min Tsai, et al.
Published: (2017-10-01)

Non-invasive respiratory support in patients with severe community-acquired pneumonia
by: S. V. Korotchenko, et al.
Published: (2023-04-01)

Predictors and etiology of healthcare-associated infections in patients with severe community-acquired pneumonia
by: I. A. Ruslyakova, et al.
Published: (2025-02-01)

Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)

MODERN MODEL FORMATION OF DRUG PROVISION OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN KABARDINO-BALKARIA
by: A. A. Umirova, et al.
Published: (2019-07-01)

Central Hemodynamics and Extravascular Lung Water Index in Varying Degrees of Community-Acquired Pneumonia
by: S. N. Avdeykin, et al.
Published: (2015-09-01)

Community-Acquired Pneumonia in Children Caused by Pneumococci of MLSB- and M-Phenotype: Clinical Cases
by: Natalya A. Ilenkova, et al.
Published: (2017-06-01)

Persistent pathogens as risk factors of community-acquired pneumonia and acute bronchitis in children
by: O. V. Zhukova, et al.
Published: (2016-07-01)

Community-acquired pneumonia mortality trends according to age and gender: 2009 to 2019
by: João Gonçalves-Pereira, et al.
Published: (2025-08-01)

Community-acquired pneumonia in hospitalized adults: long-term morbidities and their risk factors
by: Jin H. Han, et al.
Published: (2025-07-01)

Performance of CURB-65 in predicting mortality of patients with community-acquired pneumonia in Saudi Arabia
by: Jaffar A. Al-Tawfiq, et al.
Published: (2017-10-01)

Evaluation of the Efficacy and Safety of Initial Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Middle-Aged People
by: T. V. Alexandrova, et al.
Published: (2022-07-01)

The improved prediction value of neutrophil to lymphocyte ratio to pneumonia severity scores for mortality in the older people with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-07-01)

Community-acquired Klebsiella pneumoniae liver abscess: a case complicated by metastatic lung abscesses
by: Maria Inês Matias, et al.
Published: (2020-05-01)

Current corticosteroid therapeutic strategy for community-acquired pneumonia in adults: indications, dosage, and timing
by: Seitaro Fujishima
Published: (2025-07-01)

Adherence to SATS antibiotic recommendations in patients with community acquired pneumonia in Johannesburg, South Africa
by: Murimisi Mukansi, et al.
Published: (2016-04-01)

Bacterial and viral etiology in hospitalized community acquired pneumonia with molecular methods and clinical evaluation
by: Derya Çağlayan Serin, et al.
Published: (2014-04-01)

Necrotizing Pseudomonas aeruginosa Community-Acquired Pneumonia: A Case Report and Review of the Literature
by: Satish Maharaj, et al.
Published: (2017-01-01)

Clinico-pathological study of atypical pathogens in community-acquired pneumonia: a prospective study
by: Maysaa El Sayed Zaki, et al.
Published: (2009-04-01)

The accuracy of pulmonary ultrasound in the diagnosis and monitoring of community-acquired pneumonia in women of childbearing age
by: Jun Wang, et al.
Published: (2021-04-01)

Serum cytokine levels in children with community-acquired pneumonia caused by different respiratory pathogens
by: Yuanhui Duan, et al.
Published: (2025-05-01)

The Jarisch-Herxheimer Reaction in a Child with Community-Acquired Pneumonia: a Clinical Case
by: Vladimir K. Tatochenko, et al.
Published: (2018-07-01)

Free erythrocyte protoporphyrin fluorescence as an underrecognized prognostic marker of mortality in community-acquired pneumonia
by: Tomasz Wybranowski, et al.
Published: (2025-07-01)

Community-acquired pneumonia in patients admitted to National District Hospital in Bloemfontein: guideline adherence
by: Thornton Ford, et al.
Published: (2018-11-01)

PHARMACOECONOMIC EVALUATION OF ANTI-PNEUMOCOCCAL VACCINATION IN RISK GROUPS FOR THE PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA AMONG ADULTS IN THE ASTRAKHAN REGION
by: E. A. Orlova, et al.
Published: (2021-05-01)

Polymorphism of genes associated with infectious lung diseases in Northern Asian populations and in patients with community-acquired pneumonia
by: S. V. Mikhailova, et al.
Published: (2021-06-01)

Comparative effectiveness of amoxicillin versus amoxicillin‐clavulanate among adults with acute sinusitis in emergency department and urgent care settings
by: Suzette A. Rovelsky, et al.
Published: (2021-06-01)